Examples of excipients include fillers, coatings, binders, and dyes
6 In addition, users of these medications have reported other unexpected effects such as alopecia, suicidal ideation, and aspiration, which the FDA is now investigating
Liraglutide has also been seen to inhibit tau-hyperphosphorylation in DR, thus protecting RGCs from degeneration [91]
Unapproved peptides, such as Retatrutide, have not been assessed by the TGA for safety, quality or effectiveness
Current head-to-head evidence suggests tirzepatide may produce greater average weight loss than semaglutide
Policy changes like the Inflation Reduction Acts $2,000 out-of-pocket (OOP) cap for Medicare Part D beneficiaries may offer some relief, as patients who reach the cap pay $0 thereafter, but they also risk prompting payers to tighten coverage for high-cost drugs, especially those indicated for obesity